Toripalimab vs Dacarbazine as First-Line Therapy for Advanced Melanoma of Acral Subtype
X. N. SHENG, Hongxia Li, Dongyuan Zhu, Xiaoshi Zhang et al.
Journal
JAMA Oncology
Topics
Cutaneous Melanoma Detection and Management
article
Toripalimab vs Dacarbazine as First-Line Therapy for Advanced Melanoma of Acral Subtype
X. N. SHENG, Hongxia Li, Dongyuan Zhu, Xiaoshi Zhang, Hao Yu, Ruichao Zeng, L. Wu, Q. Gao, D. Wu, Gang Huang, Xieqiao Yan, Chunlei Jin, Ke Li, Jianjun Zou, Yu Chen, Jun Guo, Meiyu Fang, Jing Chen, Bixia Tang, Jing Xu, Wenbo Yu, Junliang Li
article en
Abstract
No abstract available for this paper.
Publication Tag
JAMA OncologyVol. 12(3)
Institutions
Union Hospital (HK), Sun Yat-sen University (CN), Jilin University (CN), Peking University (CN), Kunming Medical University (CN), Peking University Cancer Hospital (CN), Zhejiang Cancer Hospital (CN), Shandong Tumor Hospital (CN), Hunan Cancer Hospital (CN), First Hospital of Jilin University (CN), Henan Cancer Hospital (CN), Sun Yat-sen University Cancer Center (CN), Ministry of Education (ET), Fujian Provincial Cancer Hospital (CN), Shandong First Medical University (CN), Hefei First People's Hospital (CN), Huazhong University of Science and Technology (CN)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Toripalimab vs Dacarbazine as First-Line Therapy for Advanced Melanoma of Acral Subtype — X. N. SHENG, Hongxia Li, et al. · JAMA Oncology (2026) | TGRS Research Map | TGRS